Kawasaki, Japan

Eikou Shimizu

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eikou Shimizu. Retrieved from https://idiyas.com/inventor/eikou-shimizu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eikou Shimizu: Innovator in Antitumor Antibiotics

Introduction

Eikou Shimizu is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor antibiotics. His work has the potential to impact cancer treatment positively.

Latest Patents

Eikou Shimizu holds a patent for a high molecular weight peptide antibiotic designated as AN-7D. This innovative antibiotic is recognized for its effectiveness as an agent in combating tumors. The patent showcases his dedication to advancing medical science and improving therapeutic options.

Career Highlights

Shimizu is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His role at Ajinomoto has allowed him to focus on research and development, contributing to groundbreaking advancements in antibiotic therapies.

Collaborations

Throughout his career, Eikou Shimizu has collaborated with esteemed colleagues such as Shigezo Udaka and Shigeyoshi Miyashiro. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Eikou Shimizu's work in developing the AN-7D antibiotic exemplifies his commitment to advancing medical treatments. His contributions to the field of pharmaceuticals highlight the importance of innovation in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…